Synthesis and Evaluation of Troponoids as a New Class of Antibiotics

  • Feng Cao
  • , Cari Orth
  • , Maureen J. Donlin
  • , Patrick Adegboyega
  • , Marvin J. Meyers
  • , Ryan P. Murelli
  • , Mohamed Elagawany
  • , Bahaa Elgendy
  • , John E. Tavis

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Novel antibiotics are urgently needed. The troponoids [tropones, tropolones, and α-hydroxytropolones (α-HT)] can have anti-bacterial activity. We synthesized or purchased 92 troponoids and evaluated their antibacterial activities against Staphylococcus aureus, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa. Preliminary hits were assessed for minimum inhibitory concentrations (MIC80) and cytotoxicity (CC50) against human hepatoma cells. Sixteen troponoids inhibited S. aureus/E. coli/A. baumannii growth by ≥80% growth at <30 μM with CC50 values >50 μM. Two selected tropolones (63 and 285) inhibited 18 methicillin-resistant S. aureus (MRSA) strains with similar MIC80 values as against a reference strain. Two selected thiotropolones (284 and 363) inhibited multidrug-resistant (MDR) E. coli with MIC80 ≤30 μM. One α-HT (261) inhibited MDR-A. baumannii with MIC80 ≤30 μM. This study opens new avenues for development of novel troponoid antibiotics to address the critical need to combat MDR bacterial infections.

Original languageEnglish
Pages (from-to)15125-15133
Number of pages9
JournalACS Omega
Volume3
Issue number11
DOIs
StatePublished - Nov 8 2018

Fingerprint

Dive into the research topics of 'Synthesis and Evaluation of Troponoids as a New Class of Antibiotics'. Together they form a unique fingerprint.

Cite this